OncoTherapy Science, Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
OncoTherapy Science, Inc.
OncoTherapy Science, Inc. (オンコセラピー・サイエンス株式会社, 4564), Pharmaceutical. A board of 8 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YHRD, filed 2026-06-23. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2022-03-31 | 1.2 | −2.6 | 2.7 | −13.72 | — | 67 |
| 2023-03-31 | 1.1 | −1.1 | 1.5 | −5.81 | — | 60 |
| 2024-03-31 | 0.6 | −1.3 | 0.9 | −6.05 | — | 54 |
| 2025-03-31 | 0.8 | −0.8 | 1.2 | −3.12 | — | 47 |
| 2026-03-31 | 0.8 | −0.9 | 2.4 | −2.77 | — | 46 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown